What is the maximum recommended dose of guaifenesin (expectorant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Guaifenesin

The maximum recommended dose of guaifenesin is 2,400 mg per day, administered as 400 mg every 4 hours (up to 6 times daily) for immediate-release formulations, or 1,200 mg every 12 hours for extended-release formulations. 1

Dosing Regimens

Immediate-Release Formulations

  • Standard dosing: 200-400 mg every 4 hours 1
  • Maximum daily dose: 2,400 mg (400 mg × 6 doses) 1
  • Multiple daily doses are required to maintain 24-hour therapeutic effect due to guaifenesin's short half-life 1

Extended-Release Formulations

  • Standard dosing: 600-1,200 mg every 12 hours 2
  • Maximum single dose: 1,200 mg 2
  • Maximum daily dose: 2,400 mg (1,200 mg × 2 doses) 2, 3
  • Extended-release formulations provide convenience with 12-hourly dosing compared to immediate-release products 1

Clinical Context

The dosing range allows flexible dose titration to increase plasma concentrations as needed for symptom control 1. Extended-release guaifenesin has been demonstrated to be bioequivalent to corresponding over-the-counter monograph doses of immediate-release guaifenesin at steady state 2.

Safety Considerations

  • Guaifenesin has a well-established and favorable safety profile in adult and pediatric populations 1
  • In a post-marketing surveillance study of 552 adults taking extended-release guaifenesin 1,200 mg every 12 hours for 7 days, all adverse events were mild in severity with no serious adverse events or deaths 3
  • Critical warning: One case report documented a fatal overdose with guaifenesin at 25.0 μg/mL in femoral blood, resulting in central nervous system depression and asystole approximately 2 hours after ingestion 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.